Market Tracker

09/01 7:02am ET

Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.625
Data as of Aug 29
 +0.015 / +2.46%
Today’s Change
0.40
Today|||52-Week Range
1.10
+35.16%
Year-to-Date
No recent news for Mast Therapeutics Inc.

Today’s Trading

Previous close0.61
Today’s open0.62
Day’s range0.60 - 0.63
Volume531,283
Average volume (3 months)876,527
Market cap$76.0M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+15.15%
Earnings growth (this year)+8.93%
Earnings growth (next 5 years)+57.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.34

Competitors

 Today’s
change
Today’s
% change
GLMDGalmed Pharmaceutica...-0.01-0.15%
ADXSAdvaxis Inc+0.15+4.02%
CYCCCyclacel Pharmaceuti...-0.01-0.29%
CPXXCelator Pharmaceutic...+0.08+2.95%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$0.00
Annual profit (last year)-$21.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Brian M. Culley
President, Chief Operating Officer &
Secretary
Patrick L. Keran
Corporate headquarters
San Diego, California

Forecasts